PD-L1 regulation revisited: impact on immunotherapeutic strategies

G Lucibello, B Mograbi, G Milano, P Hofman… - Trends in Molecular …, 2021 - cell.com
A particularly promising cancer treatment is the use of monoclonal antibodies (mAbs)
against immune checkpoints (ie, immune checkpoint inhibitors; ICIs). However, many …
被引用次数：39 相关文章

PD-L1 regulation revisited: impact on immunotherapeutic strategies

G Lucibello, B Mograbi, G Milano, P Hofman… - Trends in Molecular …, 2021 - cell.com
A particularly promising cancer treatment is the use of monoclonal antibodies (mAbs)
against immune checkpoints (ie, immune checkpoint inhibitors; ICIs). However, many …

PD-L1 regulation revisited: impact on immunotherapeutic strategies

G Lucibello, B Mograbi, G Milano, P Hofman… - Trends in Molecular …, 2021 - Elsevier
HighlightsProgrammed cell death receptor 1 (PD-L1) expression is the result of multiple
layers of regulation, from gene transcription to protein post-translational modifications.PD-L1 …

PD-L1 regulation revisited: impact on immunotherapeutic strategies.

G Lucibello, B Mograbi, G Milano… - Trends in Molecular …, 2021 - europepmc.org
PD-L1 regulation revisited: impact on immunotherapeutic strategies. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

PD-L1 regulation revisited: impact on immunotherapeutic strategies

G Lucibello, B Mograbi, G Milano… - Trends in …, 2021 - pubmed.ncbi.nlm.nih.gov
A particularly promising cancer treatment is the use of monoclonal antibodies (mAbs)
against immune checkpoints (ie, immune checkpoint inhibitors; ICIs). However, many …

PD-L1 regulation revisited: impact on immunotherapeutic strategies

G Lucibello, B Mograbi, G Milano, P Hofman… - Trends in Molecular …, 2021 - Elsevier
A particularly promising cancer treatment is the use of monoclonal antibodies (mAbs)
against immune checkpoints (ie, immune checkpoint inhibitors; ICIs). However, many …